.png){kind=icon}
.png){kind=icon}
Return
Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States
.png){kind=icon}
OA
AI
M
C
S
DOI：10.1002/alz.71628.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Secondary prevention treatments for Alzheimer's disease (AD) that are currently in late-stage clinical trials may preserve productivity and workforce participation.
Keywords:
Alzheimer's disease
cognitive impairment
earnings
labor
workforce
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
0
Papers:
511
Citations:
0